More Effective Cancer Immunotherapies Without Side Effects?

Potential drug target for difficult-to-treat breast cancer: RNA-binding proteins

RNA-Binding Proteins: Molecular Targeted Therapy for Difficult-to-Treat Breast Cancer

Poorer survival in obese colorectal cancer patients possibly linked to lower chemotherapy doses